You are here: 
text zoom : S | M | L
Printer Friendly Version
Contact Details

The Robinson Institute
Ground Floor, Norwich Centre
55 King William Road
North Adelaide
SA 5006 Australia

Telephone: +61 8 8303 8166
Email

Early Development

Research Leader: Associate Professor Jeremy Thompson

The Early Development group studies the metabolic and cell signalling involved in the earliest events of mammalian development. Specifically, the group is interested in how oocytes mature and how early embryos grow, and what the impact of the environment that surrounds oocytes and embryos has on their growth, both in the short and long term.

This is important as we now realise that change in the "micro-environment" during the time oocytes mature and embryos are formed can have effects on not only early development, but on fetal and placental development and even health of the child and potentially the adult. This is particularly concerning considering that 3% of Australian babies are created using IVF techniques, which is an "artificial" environment that provides sufficient support for early development to proceed, yet may leave an
unmeasured legacy later in life.

This work focuses on the role of oxygen concentration and associated signalling mechanisms, energy substrate utilisation and metabolism and cellular signalling in response to metabolism and, finally, how peptide hormones produced by the reproductive tract affect metabolic and
developmental profiles.

The group has been active in developing commercial products for the assisted reproductive technology industry, in both clinical and agricultural applications. Specifically, developing nutritive solutions for human oocytes and embryos (and for other species), which are then manufactured and marketed by companies.

Our research has shown that the metabolic environment surrounding oocytes during the first hour of in vitro maturation is critical to subsequent oocyte developmental competence. This is relevant to practice, as many operators aspirate oocytes with simple buffered solutions. The group has also developed new media systems for human in vitro maturation that significantly support maturation, which are currently under clinical trial evaluation.

Research Priorities:

  • Oocyte maturation
  • Metabolic signalling and regulating oocyte competence
  • Role of oocyte secreted factor regulating oocyte competence
  • Role of oxygen and Hypoxia Inducible Factor in Reproductive Biology
  • Role in oocyte maturation and ovarian function, early embryo development and placental development and function
  • Production of clinical and veterinary products for more efficient delivery of reproductive technologies

 For more information about IVF Solutions please click here


Follow Us

   

Visit Robinson Institute Blog

Summer 2012 Newsletter

In this issue; Improving heart health for women and their children, Dare to Dream gala dinner, uncovering the causes of stillbirth, silence for stroke success and more..

Download or read online

Funding Success

Congratulations to Robinson Institute researchers who were successful in receiving funding from the National Health & Medical Research Council.

Projects included a $1.9 million grant to investigate if magnesium sulphate given to women at risk of preterm birth can reduce the risk of death or cerebral palsy in their children.

Learn more

Annual Report

Enjoy reading about the achievements and milestones of the Robinson Institute and our researchers in our 2010 Annual Report.

Download Report

 

Evidense-Based Guidelines for Polycystic Ovary Syndrome

The Robinson Institute has been involved in the PCOS Australian Alliance to develop the world’s first evidence-based guideline for polycystic ovary syndrome (PCOS), a hormonal condition that affects approx 12% of reproductive aged women in Australia, yet up to 70% of women with PCOS remain undiagnosed.

Download Guidelines